DDX52 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.075200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.163000E-01
Normal-vs-Stage2
5.621800E-01
Normal-vs-Stage3
2.242600E-01
Normal-vs-Stage4
9.055600E-01
Stage1-vs-Stage2
6.445200E-01
Stage1-vs-Stage3
5.450800E-01
Stage1-vs-Stage4
2.344600E-01
Stage2-vs-Stage3
3.448200E-01
Stage2-vs-Stage4
4.156400E-01
Stage3-vs-Stage4
2.197400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.612800E-01
Normal-vs-AfricanAmerican
7.556800E-01
Normal-vs-Asian
6.605000E-01
Caucasian-vs-AfricanAmerican
1.203380E-01
Caucasian-vs-Asian
8.958000E-01
AfricanAmerican-vs-Asian
3.784600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.878800E-01
Normal-vs-Female
5.502200E-01
Male-vs-Female
5.235200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.590800E-01
Normal-vs-Age(41-60Yrs)
8.923000E-01
Normal-vs-Age(61-80Yrs)
3.697200E-01
Normal-vs-Age(81-100Yrs)
2.290600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.248400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.055000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.150600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.037600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.137400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.244200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.419000E-01
Normal-vs-Daily Drinker
1.420800E-01
Normal-vs-Weekly Drinker
2.988200E-01
Normal-vs-Occasional Drinker
9.551400E-01
Normal-vs-Social Drinker
8.188600E-01
Non Drinker-vs-Daily Drinker
2.928000E-01
Non Drinker-vs-Weekly Drinker
9.858600E-01
Non Drinker-vs-Occasional Drinker
4.163800E-02
Non Drinker-vs-Social Drinker
1.255980E-01
Daily Drinker-vs-Weekly Drinker
4.195800E-01
Daily Drinker-vs-Occasional Drinker
9.978100E-03
Daily Drinker-vs-Social Drinker
3.594500E-02
Weekly Drinker-vs-Occasional Drinker
1.047560E-01
Weekly Drinker-vs-Social Drinker
2.203000E-01
Occasional Drinker-vs-Social Drinker
7.528200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.316000E-02
Normal-vs-Grade 2
1.882020E-02
Normal-vs-Grade 3
5.940600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.877200E-01
Grade 1-vs-Grade 3
1.152230E-01
Grade 1-vs-Grade 4
8.316000E-02
Grade 2-vs-Grade 3
4.347200E-01
Grade 2-vs-Grade 4
1.882020E-02
Grade 3-vs-Grade 4
5.940600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.136400E-01
Normal-vs-NonDiabetic
4.863400E-01
Diabetic-vs-NonDiabetic
8.949600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.610400E-01
Normal-vs-NoPancreatitis
4.210200E-01
Pancreatitis-vs-NoPancreatitis
9.625600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.692000E-01
Normal-vs-N1
5.831200E-01
N0-vs-N1
3.699800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.792800E-01
Normal-vs-TP53-NonMutant
4.584600E-01
TP53-Mutant-vs-TP53-NonMutant
5.373600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
